3rd Quarter - Report
ARENTFOX SCHIFF LLP for ORGANOGENESIS INC.
Firm
Client
Income
$70,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R. 184 (Protect Medical Innovation Act of 2018), all provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN RENBERG | — |
Veterans VET
Procurement of chronic wound healing products
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES RAVITZ | — |
| DAN RENBERG | — |
Medicare/Medicaid MMM
Medicare reimbursement policy for chronic wound healing products Implementation of Public Law 115-141 (Consolidated Appropriations Act, 2018), Section 1301, regarding Medicare reimbursement policy for wound healing products
| Lobbyist | Covered position, as disclosed |
|---|---|
| SONJA NESBIT | — |
| JAMES RAVITZ | — |
| DAN RENBERG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.